Literature DB >> 116394

Deterimental effect of prolonged hypothermia in cats and monkeys with and without regional cerebral ischemia.

P A Steen, E H Soule, J D Michenfelder.   

Abstract

In a previous study occlusion of a middle cerebral artery (MCA) followed by 48 h of hypothermia (29 degrees) was lethal in 5 of 5 monkeys as compared to only 3 of 9 normothermic animals. The present study extended these observations in monkeys and cats with or without MCA occlusion. In monkeys MCA occlusion plus 48 h of hypothermia was consistently lethal. Without MCA occlusion of 2 of 3 monkeys survived, but were comatose the first 12 h post-hypothermia. In normothermic cats, MCA occlusion was lethal in only one of 5 animals whereas hypothermia was lethal in 20 of 21 cats with or without MCA occlusion. The detrimental effects of hypothermia were not favorably influenced either by hemodilution or by deliberate alterations in PaCO2. The effect of 48 h of hypothermia and rewarming on cerebral blood flow (CBF) and cerebral metabolites was evaluated in 6 normal monkeys. CBF was reduced 60 to 70 percent at 29 degrees C and returned to only a maximum of 50 percent of control with re-warming. Prior to re-warming distribution of CBF was inhomogeneous. Cerebral metabolites were borderline normal prior to re-warming but energy stores decreased while lactate increased with re-warming.

Entities:  

Mesh:

Year:  1979        PMID: 116394     DOI: 10.1161/01.str.10.5.522

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

2.  Is age-dependent, ketamine-induced apoptosis in the rat somatosensory cortex influenced by temperature?

Authors:  S Gutierrez; A Carnes; B Finucane; G Musci; W Oelsner; L Hicks; G B Russell; C Liu; C P Turner
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

Review 3.  Treatment of hypoxic-ischaemic brain damage by moderate hypothermia.

Authors:  A D Edwards; J S Wyatt; M Thoresen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

Review 4.  Postischemic hypothermia. A critical appraisal with implications for clinical treatment.

Authors:  F Colbourne; G Sutherland; D Corbett
Journal:  Mol Neurobiol       Date:  1997-06       Impact factor: 5.590

5.  Short- and long-latency somatosensory neuronal responses reveal selective brain injury and effect of hypothermia in global hypoxic ischemia.

Authors:  Dan Wu; Wei Xiong; Xiaofeng Jia; Romergryko G Geocadin; Nitish V Thakor
Journal:  J Neurophysiol       Date:  2011-12-07       Impact factor: 2.714

6.  The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage.

Authors:  J Towfighi; C Housman; D F Heitjan; R C Vannucci; J Y Yager
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Experience with prolonged induced hypothermia in severe head injury.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

8.  Systemic effects of whole-body cooling to 35 °C, 33.5 °C, and 30 °C in a piglet model of perinatal asphyxia: implications for therapeutic hypothermia.

Authors:  Aron Kerenyi; Dorottya Kelen; Stuart D Faulkner; Alan Bainbridge; Manigandan Chandrasekaran; Ernest B Cady; Xavier Golay; Nicola J Robertson
Journal:  Pediatr Res       Date:  2012-02-07       Impact factor: 3.756

9.  Pharmacologically induced reversible hypometabolic state mitigates radiation induced lethality in mice.

Authors:  Subhajit Ghosh; Namita Indracanti; Jayadev Joshi; Jharna Ray; Prem Kumar Indraganti
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

10.  Dendritic spines and pre-synaptic boutons are stable despite local deep hypothermic challenge and re-warming in vivo.

Authors:  Yicheng Xie; Shangbin Chen; Timothy Murphy
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.